WNT5A and prostate carcinoma: To determine which receptors mediate the anti-proliferative and pro-apoptotic effects of WNT5A in prostate cancer, we knocked-down each of the receptors with specific siRNAs in PC3 cells 24 h before the induction of WNT5A overexpression.